Stay updated on Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a minor site/content system revision rather than a change to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:47.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:09:27.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed from the page. This update does not change study details, eligibility criteria, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-03-18T21:54:15.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3. The previous revision label v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:15:08.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added; notices about government funding and Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T10:01:19.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page adds a government funding notice, a 'Results Submitted' indicator, and updates the revision to v3.4.1, replacing the previous 'No Results Posted' status and v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T06:52:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.